SEC 13F Intelligence

Tsfg, LLC / ABBV

Tsfg, LLC’s Abbvie Inc Position

Does Tsfg, LLC own Abbvie Inc (ABBV)? Yes127.8K shares worth $28M (+4.22% of its 13F portfolio) as of Q1 2026, up from 124.5K shares the prior filed quarter.

Position Value
$28M
Q1 2026
Shares
127.8K
% of Portfolio
+4.22%
Quarters Held
26
currently held

Position History ABBV

Reported value by quarter
Q4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $8MQ3 ’20: $9MQ4 ’20: $10MQ4 ’20Q1 ’21: $11MQ2 ’21: $12MQ3 ’21: $12MQ4 ’21: $17MQ4 ’21Q1 ’22: $19MQ2 ’22: $18MQ3 ’22: $16MQ4 ’22: $20MQ4 ’22Q1 ’23: $20MQ2 ’23: $17MQ3 ’23: $19MQ4 ’23: $19MQ4 ’23Q1 ’24: $19MQ2 ’24: $18MQ3 ’24: $21MQ4 ’24: $20MQ4 ’24Q1 ’25: $24MQ2 ’25: $22MQ3 ’25: $29MQ4 ’25: $28MQ4 ’25Q1 ’26: $28Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026127.8K$28M+4.22%
Q4 2025124.5K$28M+4.25%
Q3 2025123.4K$29M+4.54%
Q2 2025120.2K$22M+4.04%
Q1 2025116.4K$24M+4.99%
Q4 2024114.6K$20M+4.18%
Q3 2024104.7K$21M+4.51%
Q2 2024106.3K$18M+4.26%
Q1 2024106.5K$19M+4.89%
Q4 2023125.4K$19M+6.13%
Q3 2023128.0K$19M+6.80%
Q2 2023124.6K$17M+6.26%
Q1 2023123.7K$20M+7.31%
Q4 2022125.4K$20M+8.05%
Q3 2022120.7K$16M+7.59%
Q2 2022114.4K$18M+7.53%
Q1 2022119.3K$19M+7.01%
Q4 2021122.0K$17M+5.75%
Q3 2021110.1K$12M+4.63%
Q2 2021103.6K$12M+4.70%
Q1 2021100.6K$11M+5.53%
Q4 202097.4K$10M+5.58%
Q3 202098.9K$9M+5.15%
Q2 202085.5K$8M+5.54%
Q1 202073.5K$6M+5.00%
Q4 201973.7K$7M+4.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tsfg, LLC’s full portfolio or all institutional holders of ABBV.